Scientists in clinical labs worldwide have worked night and day in the COVID-19 pandemic to develop, validate, and implement new diagnostic tests for patients believed to be infected by the SARS-CoV-2 virus. While each lab’s experiences are slightly different, there are certain universal themes. We spoke with Dr. Thomas Juretzek, a molecular biologist at the Carl-Thiem-Klinikum (CTK) Hospital in Cottbus, Germany, to learn about how he got an in-house screening assay up and running.

Juretzek used the Luminex ® CoV Extended Panel” href=”https://www.luminexcorp.com/covid19-testing-solutions/#molecular”>Luminex NxTAG^® CoV Extended Panel, which was implemented in parallel to the